Hct on admission to OSH was 39 and dropped to 27 with hydration and also continued BRBPR.
Today, she had another large bloody diarrhea and hct 23.7.
They did not have the radioactive material to conduct study and delay in testing led patient and family to request transfer.
Family History: Mother with diverticulitis c/b diverticular abscess requiring surgery, no GI neoplasms or IBD, Grandmother with Diabetes, mother with CAD, HTN, HLD; father with  Physical Exam: Admission PE: VS: 98.9, 115/61, 78, 18, 97%RA GENERAL: Well-appearing in NAD, comfortable, appropriate.
NEURO: Awake, A&Ox3, CNs II-XII grossly intact,  Discharge PE:   Pertinent Results: Admission labs:  [**2148-6-4**] 01:13AM BLOOD WBC-10.0 RBC-3.10* Hgb-9.9* Hct-29.5* MCV-95 MCH-31.9 MCHC-33.6 RDW-15.2 Plt Ct-184 [**2148-6-4**] 10:35AM BLOOD Hgb-9.7* Hct-29.2* [**2148-6-4**] 07:48PM BLOOD Hct-29.5* [**2148-6-4**] 01:13AM BLOOD PT-12.7* PTT-26.0 INR(PT)-1.2* [**2148-6-4**] 01:13AM BLOOD Glucose-96 UreaN-16 Creat-0.6 Na-137 K-3.7 Cl-105 HCO3-22 AnGap-14 [**2148-6-4**] 01:13AM BLOOD Calcium-8.3* Phos-3.6 Mg-1.8  LENIs IMPRESSION: 1.
# diverticular bleed:  The patient was transferred to [**Hospital1 18**] for persistent BRBPR, which was thought to be [**2-22**] diverticular bleed.
Hct was stable despite initiation of heparin drip.
By the end of the hospitalization, the patient was having normal bowel movements, without any evidence of bright red blood; her stools were also occult blood negative.
The heparin drip was later stopped and the patient was discharged on lovenox bridge until coumadin is therapeutic with INR ranging from [**2-23**].
Once the INR is [**2-23**] for at least 24 hours, the lovenox can be discontinued.
She will need repeat ultrasound in the three months to assess for resolution of clot, at which time if resolution if proven, consideration can be given to cessation of anticoagulation, this decision will need to be made by her primary care physician.
- The patient was discharged on lovenox which will have to be continued until INR is therapeutic, ranging from [**2-23**].
Coumadin 3 mg Tablet Sig: One (1) Tablet PO once a day: titrate to INR [**2-23**] 10. enoxaparin 100 mg/mL Syringe Sig: Ninety (90) mg Subcutaneous every twelve (12) hours: please stop once INR is between 2 and 3 for at least 24 hours.
We monitored your vital signs and blood levels closely.
Please check daily INRs with goaL INR between [**2-23**].
We made the following changes to your medications: STOP Meloxicam --> this increases your risk of bleeding STOP Prempro --> hormones can increase your risk to develop blood clots  START Coumadin 3 mg daily START Lovenox 90 mg injections subcutaneously every 12 hours  Followup Instructions: Please see your primary care doctor within one week of leaving the rehab facility.
